Saturday 17 October 2026
Export MOLN’s income statement to Excel — free account
Molecular Partners AG Sponsored ADR
MOLN Healthcare Biotechnology
In the quarter to June 2026, revenue fell 98.9%, EPS grew 34.3% and free cash flow grew 23.8%, each against the same quarter a year earlier.
3.56
0.09
−2.47%
Follow MOLN
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
9.08 | 8.61 | 9.21 | 7.05 | |
Current Ratio |
9.28 | 8.79 | 9.42 | 7.27 | |
Net Debt/EBITDA |
9.10 | 7.20 | 6.09 | 5.18 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.91 | 0.72 | 1.08 | 0.79 | |
Capex/Depreciation |
(0.08) | (0.26) | 0.00 | (0.04) | |
Interest Coverage |
(76.72) | (41.17) | (1,225.33) | (1,237.17) | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.36) | (0.32) | (0.48) | (0.35) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.36) | (0.32) | (0.48) | (0.35) | |
Cash per Share |
3.51 | 3.01 | 2.68 | 2.22 | |
Shareholders Equity per Share |
3.21 | 2.60 | 2.33 | 1.91 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.21 | 2.60 | 2.33 | 1.91 | |
Free Cash Flow |
(13.59) | (11.90) | (18.18) | (13.53) | |
Working Capital |
121.47 | 103.62 | 94.60 | 77.96 | |
Capital Expenditures |
(0.06) | (0.14) | — | (0.03) | |
Net Current Asset Value |
115.38 | 90.65 | 81.32 | 68.68 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
| Other line items | |||||
Average Receivables |
3.23 | 2.42 | 3.69 | 3.03 | |
Average Payables |
2.70 | 2.12 | 2.56 | 2.31 | |
Average Assets |
159.16 | 151.66 | 134.41 | 123.20 | |
Average Common Equity |
139.86 | 128.92 | 114.98 | 101.69 |
Columns are period end dates